Skip to content

Evaluating the Efficacy of a 60-day Emotion Regulation Journal

Evaluating the Efficacy of a 60-day Self-guided Emotion Regulation Journal

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05738122
Enrollment
30
Registered
2023-02-21
Start date
2023-01-18
Completion date
2023-11-11
Last updated
2025-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emotional Regulation, Mental Health

Brief summary

Participants randomized to the intervention group will receive a physical copy of the 60-day emotion regulation journal during the baseline meeting. Participants will also be introduced the purpose of the journal and its intended usage (i.e., daily journaling). Intervention participants will not be offered guidance or feedback on the journal after these initial instructions, in order to emulate an ad libitum usage. Control group participants will not receive any contact with the researchers outside of the planned questionnaires and to receive their journal at the two-month timepoint.

Interventions

OTHER60-Day self-guided Emotion Regulation Journal

A 60-day self guided journal with activities designed to be completed daily to improve an individual's emotion regulation abilities and habits

Sponsors

Switch Research
CollaboratorUNKNOWN
Mathematics of Information Technology and Complex Systems
CollaboratorUNKNOWN
University of Victoria
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* (1) being 18+ years old (2) being fluent in English, (3) currently living in the Greater Victoria area, (4) self-reporting no previously diagnosed mental illness or psychiatric conditions, and (5) scoring a mean of \<4.6 on the Cognitive Reappraisal, and mean of \>3.14 on the Expressive Suppression subscales of the Emotion Regulation Questionnaire (based on previous mean data)

Exclusion criteria

* Scoring a mean of ≥4.6 on the Cognitive Reappraisal or a mean of ≤3.14 on the Expressive Suppression subscales of the Emotion Regulation Questionnaire, currently receiving or seeking therapy for a mental illness, a current or previous diagnosis of mental illness, or self-identifying as neurodivergent.

Design outcomes

Primary

MeasureTime frameDescription
Participant Emotion Regulation2 weeks, 1-month, 2-months, 60 day exit interview, 90 days follow upChange in participants' emotion regulation abilities and habits assessed using the Emotion Regulation Questionnaire.

Secondary

MeasureTime frameDescription
Experience using journal60 daysUsability and user experience of intervention group collected during exit interview
DemographicsBaselineAge, preferred gender, socio-economic status, ethnicity, educational attainment, and employment status will be collected.
Mental Health2 weeks, 1-month, 2-months, and 3-month follow up for intervention groupDepression and anxiety will be assessed using the Hospital Anxiety and Depression Scale. There is a minimum score of 0 and a maximum score of 21 for each anxiety and depression. Individuals with a score of greater than 8 are considered to have considerable symptoms of anxiety and/or depression.
Subjective Well-Being2 weeks, 1-month, 2-months, and 3-month follow up for intervention groupSubjective well-being will be assessed using the Warwick-Edinburgh Mental Wellbeing Scale. There is a minimum score of 14 and a maximum score of 70. Scores above 51 are above mean population mental well-being while a score below 51 is below mean population mental well-being.
Adherence2 weeks, 1-month, 2-monthsParticipants' adherence to the 60-days of activities in the journal assessed using three items: Currently, what is the last day of the journal you have completed?; Have you skipped or not completed any days prior to the latest day you have completed?; and Approximately how many minutes do you spend completing a day, within the journal?
Physical Activity and Sedentary Behaviour2 weeks, 1-month, 2-month, and 3-month follow up for intervention groupPast week hours of sitting, walking, mild, moderate, and vigorous physical activity will be assessed using a modified version of the International Physical Activity Questionnaire. A HIGH score consists of vigorous intensity activity on at least 3 days OR 7 or more days of any combination of walking, moderate intensity or vigorous intensity activities. A MODERATE score consists of 3 or more days of vigorous intensity activity and/or walking of at least 30 minutes per day OR 5 or more days of moderate intensity activity and/or walking of at least 30 minutes per day OR 5 or more days of any combination of walking, moderate intensity or vigorous intensity activities. A LOW score is not achieving the high or moderate physical activity levels.
Screen Time2 weeks, 1-month, 2-month, and 3-month follow up for intervention groupPast week average weekday and weekend occupational and recreational (i.e., leisure) screen time hours will be assessed using four bespoke items (e.g., In the last seven days, on an average weekday, how many hours did you spend using screens for recreational purposes (e.g., watching TV, playing video games)?)
Sleep2 weeks, 1-month, 2-month, and 3-month follow up for intervention groupPast week average hours of sleep will be assessed using an adapted item from the Pittsburgh Sleep Quality Assessment: 20 During the past week, how many hours of actual sleep did you get at night?. The minimum score is 0 representing 7 or more hours of sleep and the maximum score is 3 representing less than 5 hours of sleep. The higher the score, the worse the sleep duration.
Self-Compassion2 weeks, 1-month, 2-months, and 3-month follow up for intervention groupSelf-Compassion will be assessed using the full version of the Self-Compassion Scale. Minimum score is 1 and Maximum score is 5. Scores from 1-2.5 indicate low self-compassion, 2.5-3.5 indicates moderate, and 3.5-5 indicates high self-compassion.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026